🟡 77/100

Review before taking

  • Niacin: 80mg is 2.3× the Tolerable Upper Intake Level (35mg)
  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 67% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Niacin: 80mg is 2.3× the Tolerable Upper Intake Level (35mg)
ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

The product contains Niacin levels that exceed the recommended daily maximum and uses a proprietary blend, meaning the exact amounts of some ingredients are not disclosed.

Label Data

2 Capsule(s) Serving Size
15 Servings
Other Combinations Product Type
67% Evidence Coverage

Supplement Facts — Evidence Check

80 mg (400% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 2.3× (UL: 35 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 80mg UL 35mg
20 mg (133% DV)
✅ 1.8× RDA — within safe limits 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 20mg UL 40mg
Proprietary Blend
2640 mg

Other Ingredients

Magnesium Stearate Silica

Label Claims — Verification

All Other
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult Male (18-50 Years)

Product Information

📋 Directions for Use

Recommendation: Take two to four capsules per day following meals or as directed by your health care professional.

⚠️ Warnings & Precautions

Warning: Keep out of the reach of children.

If tamper resistant seals are broken do not use this product.

🧪 Formulation Notes

Male Complex supports men's health with essential hormones and nutrient. Supplementing the body with amino acids, herbals and dehydrated glandulars helps the body to repair tissue and improve normal function of the body.

Additional Information

Bringing balance back to life

Product Details

UPC / SKU 3 58301 27717 2
DSLD Entry Date 2020-08-23
Product Type Other Combinations
Form Capsule
DSLD ID 231624
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →